STOCK TITAN

InfuSystem Holdings, Inc. - INFU STOCK NEWS

Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.

InfuSystem Holdings, Inc. (NYSE American: INFU) is a growing healthcare service provider specializing in delivering infusion pumps and related products and services to patients across the United States and Canada. The company is headquartered in Rochester Hills, Michigan, and operates from five strategically located facilities to ensure comprehensive coverage. InfuSystem facilitates outpatient care through a two-platform model: Patient Services and Device Solutions.

Patient Services offers a last-mile solution for clinic-to-home healthcare. This segment includes Oncology, Pain Management, Wound Therapy, and Lymphedema services. It focuses on delivering complex durable medical equipment directly to patients, ensuring they receive continuous care at home or other non-hospital settings.

Device Solutions supports the Patient Services platform by providing direct payer rentals, pump and consumable sales, and biomedical services and repair. This segment's goal is to enhance service orientation and secure additional business from its direct payer clients.

InfuSystem's innovative approach and strategic partnerships have made it a leader in the healthcare service sector. Recently, the company announced a sales and marketing partnership with Dignitana AB, a leader in scalp cooling technology. This collaboration allows InfuSystem to offer the FDA-cleared DigniCap Scalp Cooling System to help minimize hair loss for cancer patients undergoing chemotherapy. This partnership highlights InfuSystem's commitment to enhancing patient care and expanding its product offerings.

InfuSystem boasts a robust financial position, underpinned by its diversified service offerings and strong market presence. The company continues to explore new opportunities to grow and enhance its service delivery, ensuring that it remains at the forefront of the healthcare industry.

Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) will release its first quarter 2021 financial results on May 6, 2021, before the market opens. The Company provides outpatient care for durable medical equipment manufacturers and health care providers. A conference call for investors is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the results. Investors can participate via phone or a live webcast, with a replay available for 90 days after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
conferences earnings
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) has announced the acquisition of assets from OB Healthcare Corporation, a Texas-based biomedical services firm. This strategic move enhances InfuSystem's Durable Medical Equipment Services (DME) platform, following a recent acquisition of FilAMed. The combination of OB Healthcare's on-site service capabilities and FilAMed's remote repair expertise aims to expand InfuSystem's market opportunities in acute care. CEO Richard DiIorio emphasized the synergy between both companies, which is expected to improve service offerings for their healthcare clients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
-
Rhea-AI Summary

InfuSystem Holdings (NYSE American: INFU) will present at Sidoti’s Spring 2021 Virtual Conference on March 25, 2021, at 9:15 a.m. ET. CEO Rich DiIorio and CFO Barry Steele will discuss the company's role as a leading healthcare service provider facilitating outpatient care for durable medical equipment. Their services include Integrated Therapy Services and Durable Medical Equipment Services. Management will also hold one-on-one meetings with investors on March 24-25. A recorded webcast will be available afterward on InfuSystem’s website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.83%
Tags
conferences
Rhea-AI Summary

InfuSystem Holdings reported a remarkable financial performance for the full year 2020, reflecting a 20% increase in net revenues, reaching $97.4 million, and a 15.9 million surge in net income, totaling $17.3 million. Adjusted EBITDA climbed 44% to $26.2 million. For 2021, the company reaffirms its guidance with projected net revenues of $107 million - $110 million and adjusted EBITDA of $29 million - $30 million. Notably, the fourth quarter saw a 14% revenue increase, driven by significant growth in oncology and DME services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.53%
Tags
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) will release its fourth quarter and full year 2020 financial results on March 17, 2021, before market opening. The company provides outpatient care services for durable medical equipment. Following the results announcement, a conference call will be held at 9:00 a.m. Eastern Time to discuss the financials. Investors can participate by calling (833) 366-1127 or through a live webcast on the company’s website. A replay will be available for 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.93%
Tags
conferences earnings
-
Rhea-AI Summary

InfuSystem Holdings announces the promotion of Carrie Lachance to President, adding to her current role as Chief Operating Officer. CEO Richard DiIorio praised her leadership in patient and customer care. This leadership change aims to strengthen the company’s growth strategy and enhance its two operational platforms: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME). Lachance, with over 20 years of healthcare experience, focuses on scaling new therapies and products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.92%
Tags
management
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) announced a new $75 million revolving credit facility with JPMorgan Chase Bank, replacing a $49 million facility. Effective February 5, 2021, this facility enhances liquidity and financial flexibility, allowing the company to capitalize on growth opportunities in Integrated Therapy Services and Durable Medical Equipment Services. With this facility, InfuSystem's liquidity increases to over $45 million from approximately $20 million previously. The facility features a five-year term and an interest rate tied to the company's Total Leverage Ratio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.42%
Tags
none
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) has announced the acquisition of FilAMed, a biomedical services company based in Bakersfield, CA. Although the terms of the transaction were not disclosed, CEO Richard DiIorio emphasized the strategic importance of this acquisition in expanding InfuSystem's capabilities within its Durable Medical Equipment Services (DME) platform. The acquisition aims to enhance service offerings such as compression devices and patient monitors, while providing a broader range of services and facilitating entry into the acute care market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE: INFU) has announced its financial guidance for 2021, projecting net revenues of $107 million to $110 million, Adjusted EBITDA of $29 million to $30 million, and operating cash flow of $21 million to $23 million. Management anticipates strong growth driven by its Integrated Therapy Services (ITS) Segment, particularly in Pain Management and Negative Pressure Wound Therapy. Despite expecting tailwinds from COVID-19, they remain cautious about potential impacts on operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.51%
Tags
none
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) will be participating in the 13th Annual LD Micro Main Event on December 15, 2020, at 3:00 p.m. ET. The presentation will be conducted virtually by CEO Rich DiIorio and CFO Barry Steele.

InfuSystem is a prominent health care service provider specializing in outpatient care for durable medical equipment. The company operates through two platforms: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services), servicing areas including Oncology, Pain Management, and Wound Therapy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.51%
Tags
conferences

FAQ

What is the current stock price of InfuSystem Holdings (INFU)?

The current stock price of InfuSystem Holdings (INFU) is $9.02 as of December 4, 2024.

What is the market cap of InfuSystem Holdings (INFU)?

The market cap of InfuSystem Holdings (INFU) is approximately 192.9M.

What services does InfuSystem Holdings, Inc. provide?

InfuSystem provides infusion pumps and related services to patients at home, in oncology clinics, ambulatory surgery centers, and other care sites.

What are the two platforms of InfuSystem's services?

InfuSystem operates through Patient Services, which includes Oncology, Pain Management, and Wound Therapy, and Device Solutions, which provides rentals, sales, and biomedical services.

Where is InfuSystem Holdings, Inc. headquartered?

InfuSystem Holdings, Inc. is headquartered in Rochester Hills, Michigan.

Who are InfuSystem's recent partners?

InfuSystem recently partnered with Dignitana AB to offer the DigniCap Scalp Cooling System, which helps minimize hair loss during chemotherapy.

What is the DigniCap Scalp Cooling System?

The DigniCap Scalp Cooling System is an FDA-cleared device designed to reduce hair loss in cancer patients undergoing chemotherapy.

What areas does InfuSystem serve?

InfuSystem serves patients across the United States and Canada.

What is the objective of the Patient Services platform?

The Patient Services platform aims to provide comprehensive clinic-to-home healthcare solutions, ensuring continuous care for patients using complex durable medical equipment.

How does the Device Solutions platform support InfuSystem?

Device Solutions enhances the Patient Services platform by offering direct payer rentals, pump and consumable sales, and biomedical services and repair.

What are InfuSystem's business segments?

InfuSystem's business segments include Oncology, Pain Management, Wound Therapy, and Lymphedema under Patient Services, and rentals, sales, and repair services under Device Solutions.

How does InfuSystem contribute to patient care?

InfuSystem ensures patients receive necessary medical equipment and services at home, improving their quality of life and enabling continuous treatment outside of hospital settings.

InfuSystem Holdings, Inc.

NYSE:INFU

INFU Rankings

INFU Stock Data

192.86M
19.97M
6.07%
78.98%
0.88%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
ROCHESTER HILLS